For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
A few words from…Carol Atmore
Wednesday 31 July 2024, 05:00 AM

Carol Atmore with her teenage dream car – a 1965 Volkswagen Karmann Ghia [Image: Supplied]
Dunedin specialist GP Carol Atmore is the clinical director of WellSouth PHO and a senior research fellow at the University of Otago. She likes to relax in the garden and dreams of more joy for people working in primary care
The best thing about my PHO is our people – we have an amazing team who have embraced our responsibility to equity and to be a good Te Tiriti o Waitan
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.